COMPAS enrolled a total of 538 patients across 43 centers, randomizing them 1:1 to BIOTRONIK Home Monitoring ® or conventional in-clinic care. Follow-up duration was 18 months, at the end of which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results